The couple, with the husband at 48 earning around $90,000 annually and the wife (42 at the time of pregnancy) now staying home full-time to care for their newborn, face a household income that’s effectively halved from previous levels. They have no retirement savings whatsoever, but they’ve built up about $30,000 in emergency savings. The surprise arrival of the baby adds joy but also immediate expenses like childcare alternatives (even if mom stays home), medical costs, diapers, formula, and future child-related needs. The question looms large: Is retirement still possible, or has the late start combined with new family responsibilities made it unattainable?

by
A middle-aged couple in their 40s holding a newborn baby while reviewing financial documents and a piggy bank, symbolizing late-start retirement planning challenges and hope.

“It’s never too late to start building wealth if you’re willing to get intense and follow a proven plan. With discipline, consistent investing, and smart choices, this couple can still retire comfortably—potentially with over a million dollars by age 67—without sacrificing their new family’s well-being or resorting to drastic moves like selling their home.” The … Read more

U.S. GoldMining Delivers Robust Preliminary Economic Assessment for Alaska’s Whistler Gold-Copper Project

by
Open-pit gold-copper mining operation in Alaska landscape with heavy machinery and mountainous terrain

U.S. GoldMining Inc. has released a highly positive preliminary economic assessment for its flagship Whistler Gold-Copper Project in Alaska, highlighting strong economics with an after-tax NPV of $2.04 billion, 33% IRR, and a quick 2.1-year payback at base case metal prices. The study outlines a 14.6-year open-pit mine producing 3.6 million ounces of gold equivalent … Read more

ORIC Pharmaceuticals Teases Key 2026 Catalysts, Phase 3 Plans for Prostate and Lung Cancer Drugs

by
ORIC Pharmaceuticals laboratory researchers analyzing oncology data for prostate and lung cancer drug development

“ORIC Pharmaceuticals is positioning two lead candidates for major late-stage advancement in 2026, with rinzimetostat (formerly ORIC-944) set to enter its first global Phase 3 trial in metastatic castration-resistant prostate cancer in the first half of the year, and enozertinib (ORIC-114) advancing toward registrational trials in first-line non-small cell lung cancer. The company anticipates multiple … Read more

Barclays Cuts Price Target on ACV Auctions Amid Cautious Outlook

by
Stock chart and Barclays logo overlay on ACV Auctions ticker symbol ACVA with downward arrow indicating price target cut

Barclays has lowered its price target on ACV Auctions (NYSE: ACVA) from $8 to $7 while maintaining a Hold rating, reflecting tempered expectations following the company’s recent Q4 earnings report. The adjustment highlights concerns over profitability challenges, guidance alignment, and ongoing market pressures in the wholesale used vehicle sector, despite solid revenue performance and strategic … Read more

MaxLinear (MXL) Valuation After Recent Share Price Weakness

by
Chart showing MaxLinear (MXL) stock price trend with recent weakness and valuation metrics overlay

MaxLinear’s shares have faced pressure lately, trading around $17.43 after dipping from recent highs near $20.82. Despite the pullback, the company’s strong Q4 2025 results—with revenue up 48% year-over-year—and optimistic guidance for infrastructure-driven growth in 2026, including $100-130 million from Keystone PAM4 DSPs, suggest the current valuation may offer an attractive entry point for long-term … Read more

FIGS Q4 Earnings Call Highlights: Record Revenue Surge and Strong Momentum into 2026

by
FIGS Inc. corporate logo on a financial earnings report background with upward stock chart elements

FIGS delivered a standout fourth quarter for fiscal 2025, with net revenue soaring 33% year-over-year to a record $201.9 million, surpassing expectations significantly. The company achieved robust profitability improvements, including a net income margin of 9.2% and adjusted EBITDA margin of 13.2%. Active customers reached an all-time high of over 2.9 million, up 9%, while … Read more

Jim Cramer Spotlights BWX Technologies as a Standout in Defense and Nuclear Sectors

by
BWX Technologies nuclear reactor components for defense and commercial applications, highlighting its role in naval and energy sectors.

“This has been a very good market for the defense contractors and the nuclear energy plays. So what about a company that’s in both of these businesses? I’m talking about BWX Technologies, which makes nuclear reactors for submarines and aircraft carriers. Here’s a stock that has more than tripled over the past three years, up … Read more

Momentum Cyber Hosts AIxCYBER: Unpacks the $119 Billion Bet Made on Cybersecurity as Agentic AI Rewrites the Threat Landscape

by
Alt Text for featured image : Momentum Cyber AIxCYBER event graphic highlighting $119 billion cybersecurity investment and agentic AI reshaping threats

“In 2025, the cybersecurity sector witnessed an unprecedented $119 billion deployed across more than 1,200 transactions, marking the most active year in history. Momentum Cyber’s upcoming AIxCYBER event on March 12, 2026, in Austin will dissect how agentic AI is transforming both threats and defenses, forcing a repricing of cybersecurity as essential infrastructure for the … Read more

Steven Madden: Q4 Earnings Snapshot

by
Steven Madden footwear and accessories display in retail store setting with branded shoes and handbags

“Steven Madden Ltd. (NASDAQ: SHOO) delivered a mixed but acquisition-fueled performance in the fourth quarter of fiscal 2025, with consolidated revenue surging 29.4% year-over-year to $753.7 million, largely driven by the inclusion of Kurt Geiger. Adjusted earnings per share came in at $0.48, edging past analyst expectations, while GAAP net income declined to $23.2 million … Read more

Polkadot, Solana Lead Altcoin Surge Ahead of Nvidia Earnings Call

by
Polkadot and Solana cryptocurrency logos with upward trending charts against a background of digital financial graphs and Nvidia stock elements

Polkadot (DOT) and Solana (SOL) have spearheaded a sharp rally in altcoins, with DOT surging over 20% in the last 24 hours to around $1.49 and SOL climbing more than 10% to approximately $85. This broad-based altcoin momentum comes as traders position ahead of Nvidia’s highly anticipated Q4 earnings release after market close today, amid … Read more